<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-95552</identifier>
<setSpec>0214-9168</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Temporary evolution of metabolic markers and of autoimmune disease in an model of lupus erythematosus</dc:title>
<dc:description xml:lang="en">Introduction There is an association between metabolic syndrome (MS) and systemic lupus erythematosus (SLE). Female New-Zealand Black-White first generation (BWF1) mouse is an established model of human SLE, also showing MS characteristics. We studied in this model the temporal evolution of MS and SLE markers, and their relation ship with the proportion of regulatory T cells (Tregs).Methods 32 female mice New-Zealand White (control) and 32 female mice BWF1 (SLE group) were studied during 28 weeks, determining solid food consumption and body weight. At week 8, 16, 24 and 32, animals were sacrificed, to determine: the weight of visceral adipose tissue, the proporti on of CD4+, CD4+CD25+ and Tregs cells in splenic lymphocytes, the liver and plasma triglyceride concentrations, and the plasma concentrations of glucose, insulin, leptin, anti-dsDNA antibodies, and creatinin. Results SLE mice showed, until the age of 16 weeks, signs of metabolic alterations such as hyperphagia, hyperleptinaemia, and an increased body weight, related to a high amount of visceral adipose tissue, as well as an increased proportion of Tregs cells. From the week 16 on, a drastic change ensued, with an increase in the plasma concentration of anti-dsDNA antibodies, matching the disappearance of MS signs.Conclusion The presence of leptin resistance during the first few weeks of life could explain not only the high consumption of solid diet presented by SLE mice, but also the increase in the proportion of Tregs cells (AU)</dc:description>
<dc:creator>Vilà, Laia</dc:creator>
<dc:creator>Roglans, Núria</dc:creator>
<dc:creator>Laguna, Juan C</dc:creator>
<dc:creator>Barroso, Emma</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Introducción Existe una asociación entre el síndrome metabólico (SM) y el lupus eritematoso sistémico (LES). Los ratones hembra New-Zealand Black-White de primera generación (BWF1) constituyen un modelo de LES humano y presentan características del SM. Hemos estudiado en este modelo la evolución temporal del SM y marcadores de LES, y su relación con la proporción de células T reguladoras (Tregs).Métodos Treinta y dos ratones hembra New-Zealand White (control) y 32 ratones hembra BWF1 (grupo LES) se estudiaron durante 28 semanas, determinando el consumo de dieta y el peso corporal. Los animales se sacrificaron a las 8, 16, 24 y 36 semanas de vida, determinando: el peso de tejido adiposo visceral, la proporción de células CD4+, CD4+CD25+ y Tregs en linfocitos esplénicos, concentraciones plasmáticas y hepáticas de triglicéridos, concentraciones plasmáticas de glucosa, insulina, leptina, anticuerpos anti-dsDNA y creatinina.Resultados Los ratones LES presentaron, hasta las 16 semanas de vida, signos de alteraciones metabólicas, como hiperfagia, hiperleptinemia y un peso superior a los ratones control, asociado al incremento en la masa de tejido adiposo visceral, así como una mayor proporción de células Treg. A partir de las 16&#150;24 semanas de vida, se produjo un cambio drástico, con un incremento en los niveles plasmáticos de anticuerpos anti-dsDNA, que coincidió con la desaparición de las manifestaciones de SM.Conclusiones La presencia de resistencia a la leptina en las primeras semanas de vida explicaría no solo la mayor ingesta de alimento presentada por los ratones LES, sino también la mayor proporción de células Tregs (AU)</dc:description>
<dc:source>Clín. investig. arterioscler. (Ed. impr.);22(6): 233-240, nov.-dic. 2010. ilus</dc:source>
<dc:identifier>ibc-95552</dc:identifier>
<dc:title xml:lang="es">Evolución temporal de marcadores metabólicos y de enfermedad autoinmune en un modelo de lupus eritematoso</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d8994</dc:subject>
<dc:subject>^d24379^s22032</dc:subject>
<dc:subject>^d50524^s22032</dc:subject>
<dc:subject>^d841</dc:subject>
<dc:subject>^d36032^s22032</dc:subject>
<dc:subject>^d4255</dc:subject>
<dc:subject>^d34404^s22063</dc:subject>
<dc:subject>^d1333^s22044</dc:subject>
<dc:subject>^d23568^s22002</dc:subject>
<dc:subject>^d8356^s22032</dc:subject>
<dc:type>article</dc:type>
<dc:date>201011</dc:date>
</metadata>
</record>
</ibecs-document>
